GlassScriptPhysician profile
Matthew Clavenna
NPI 1043453350
$1,717.35
in general payments reported to CMS, 2019-2025
17 companies · $336 in 2025
The $336 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $280 · 2021: $255 · 2022: $80.54 · 2023: $114 · 2024: $490 · 2025: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $840 · Education: $99.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $840.48 |
| Education | $99.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $246.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $243.17 | 2019-2024 | Dupixent |
| Aerin Medical INC. | $214.17 | 2019-2025 | |
| Optinose US, INC. | $194.24 | 2019-2025 | |
| Neurent Medical Limited | $169.11 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Intersect Ent, INC. | $156.55 | 2021-2022 | |
| Medtronic, INC. | $101.87 | 2025 | Propel, Stealthstation S8 Platform |
| Alk-Abello, INC | $93.58 | 2019-2023 | Grastek, Odactra, Ragwitek |
| Glaxosmithkline, LLC. | $83.65 | 2021-2025 | Nucala |
| Stryker Corporation | $53.18 | 2024 | Scopis Ent |
| Revance Therapeutics, INC. | $39.03 | 2025 | Daxxify |
| Genzyme Corporation | $33.17 | 2025 | |
| Jazz Pharmaceuticals INC. | $23.72 | 2021 | |
| Hikma Pharmaceuticals USA | $19.30 | 2023 | Ryaltris |
| Integra Lifesciences Corporation | $17.11 | 2023 | Codman Isocool Aht, Microfrance, Integra Duo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $15.78 | 2023 | Wakix |
| Ethicon US, LLC | $13.72 | 2025 | Surgicel Nu-Knit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Clavenna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.